Reviewed by Michael Gill, B. Sc.
25 Chronic Lymphocytic Leukemia Clinical Trials Near Me
Top Hospitals for Chronic Lymphocytic Leukemia Clinical Trials
Image of M D Anderson Cancer Center in Texas.
M D Anderson Cancer Center
Houston
11Active Trials
46All Time Trials for Chronic Lymphocytic Leukemia
1998First Chronic Lymphocytic Leukemia Trial
Image of Ohio State University Comprehensive Cancer Center in Ohio.
Ohio State University Comprehensive Cancer Center
Columbus
8Active Trials
29All Time Trials for Chronic Lymphocytic Leukemia
2008First Chronic Lymphocytic Leukemia Trial
Top Cities for Chronic Lymphocytic Leukemia Clinical Trials
Chronic Lymphocytic Leukemia Clinical Trials by Phase of Trial
Phase < 1 Chronic Lymphocytic Leukemia Clinical Trials
1Active Chronic Lymphocytic Leukemia Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
[U-13C]glucose
Chronic Lymphocytic Leukemia Clinical Trials by Age Group
18+ Chronic Lymphocytic Leukemia Clinical Trials
108Active Chronic Lymphocytic Leukemia Clinical Trials
ABBV-319JNJ-80948543BMS-986403LOXO-338VenetoclaxJNJ-67856633JNJ-75348780Cirmtuzumab
Most Recent Chronic Lymphocytic Leukemia Clinical Trials
Top Treatments for Chronic Lymphocytic Leukemia Clinical Trials
Treatment Name
Active Chronic Lymphocytic Leukemia Clinical Trials
All Time Trials for Chronic Lymphocytic Leukemia
First Recorded Chronic Lymphocytic Leukemia Trial
Ibrutinib
10
84
2012
Acalabrutinib
9
30
2014
Venetoclax
6
74
2012
Pirtobrutinib
5
7
2018
Pharmacological Study
4
22
2004
Recently Completed Studies with FDA Approved Treatments for Chronic Lymphocytic Leukemia
Treatment
Year
Sponsor
PBCAR20A
2020
Precision BioSciences, Inc.
CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
2017
Medical College of Wisconsin
Venetoclax
2016
AbbVie
Nivolumab
2015
M.D. Anderson Cancer Center

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: October 7th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.